5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.17▲ | 4.15▲ | 4.15▲ | 4.15▲ | 3.90▲ |
MA10 | 4.17▲ | 4.15▲ | 4.13▲ | 4.11▲ | 3.29▲ |
MA20 | 4.17▲ | 4.14▲ | 4.12▲ | 3.78▲ | 3.93▲ |
MA50 | 4.14▲ | 4.11▲ | 4.11▲ | 3.29▲ | N/A |
MA100 | 4.12▲ | 4.08▲ | 3.87▲ | 4.03▲ | N/A |
MA200 | 4.10▲ | 3.78▲ | 3.51▲ | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.005▲ | 0.004▲ | 0.029▲ | N/A |
RSI | 56.612▲ | 55.592▲ | 54.822▲ | 61.481▲ | 47.327▼ |
STOCH | 72.500 | 76.355 | 75.635 | 81.541▲ | 68.808 |
WILL %R | 0.000▲ | 0.000▲ | -5.000▲ | -14.183▲ | -30.836 |
CCI | 92.715 | 107.456▲ | 102.292▲ | 70.139 | 47.912 |
Friday, April 18, 2025 12:26 PM
We recently published a list of the 10 Best Rising Penny Stocks to Buy According to Analysts. In this article, we are going to take a look at where TuHURA Biosciences, Inc. (NASDAQ:HURA) stands ...
|
Friday, April 18, 2025 04:11 AM
TuHURA Biosciences, Inc. (NASDAQ:HURA) is a registration-stage biotechnology company that specializes in immuno-oncology. Its lead product IFx-2.0 is a personalized cancer vaccine. The company is ...
|
Wednesday, April 16, 2025 05:00 PM
In this article, we are going to take a look at where TuHURA Biosciences, Inc. (NASDAQ:HURA) stands against other best rising penny stocks to buy according to analysts. Small-Cap Performance in Q1 ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
23/04/25 | 4.20 | 4.205 | 4.01 | 4.20 | 106,479 |
22/04/25 | 4.25 | 4.25 | 3.75 | 4.08 | 178,143 |
21/04/25 | 4.03 | 4.4099 | 3.91 | 4.20 | 167,465 |
17/04/25 | 4.17 | 4.25 | 3.91 | 4.15 | 117,436 |
16/04/25 | 4.06 | 4.20 | 3.93 | 4.14 | 108,773 |
15/04/25 | 4.04 | 4.195 | 3.96 | 4.105 | 166,638 |
14/04/25 | 4.10 | 4.25 | 3.77 | 4.20 | 196,801 |
11/04/25 | 3.86 | 4.25 | 3.72 | 4.22 | 269,601 |
10/04/25 | 3.94 | 3.95 | 3.65 | 3.87 | 129,102 |
09/04/25 | 3.53 | 4.00 | 3.45 | 3.94 | 241,962 |
|
|
||||
|
|
||||
|
|